Yahoo Malaysia Web Search

Search results

1. finance.sina.com.cn › roll › 2024/07/064年花掉60亿再抛25.5亿定增，荣昌生物的钱花哪了？|费用_新浪财经_新...

   finance.sina.com.cn › roll › 2024/07/06

   • Cached

   23 hours ago · 荣昌生物获得了Seagen公司支付的2亿美元（约13.8亿元人民币）首付款并确认收入。 当年，公司营收14.26亿元，净利润2.76亿元，成功扭亏为盈。

2. www.infinhub.com › news › across-the-webYahoo Finance3 Reliable Dividend Stocks With Yields Above 5% You...

   www.infinhub.com › news › across-the-web

   • Cached

   14 hours ago · Pfizer reinvested some of the enormous profit its COVID-19 products generated into new sources of revenue that can keep its needle moving in the right direction. For example, the $43 billion acquisition of Seagen in 2023 gave it access to four commercial-stage cancer drugs, including Padcev.

3. Videos

   • 

     1:01

     youtube.com

     SeaGen - Sea Generation Tidal Turbine

     5 Aug 2008

     143.4K views

   • 

     3:26

     youtube.com

     Pfizer Buys Cancer-Drug Maker Seagen for $43 Billion

     13 Mar 2023

     6.6K views

   • 

     3:25

     bloomberg.com

     Pfizer Buys Cancer-Drug Maker Seagen for $43 Billion

     13 Mar 2023

   View all

4. www.vbdata.cn › intelDetail › 197475鲁卡帕利单独联合atezolizumab抑制PARP：晚期妇科和三阴性乳腺癌的Ib...

   www.vbdata.cn › intelDetail › 197475

   • Cached

   23 hours ago · 鲁卡帕利单独联合atezolizumab抑制PARP：晚期妇科和三阴性乳腺癌的Ib期耦合临床研究 PARP inhibition with rucaparib alone followed by combination with atezolizumab: Phase Ib COUPLET clinical study in advanced gynaecological and triple-negative breast cancers

5. finance.sina.cn › 2024/07/06 › detail-inccfahz62177204年花掉60亿再抛25.5亿定增，荣昌生物的钱花哪了？_手机新浪网

   finance.sina.cn › 2024/07/06 › detail-inccfahz6217720

   • Cached

   23 hours ago · 2021年8月，公司授权Seagen公司获得维迪西妥单抗在亚洲（不包括日本和新加坡）以外地区的全球开发和商业化权益。荣昌生物获得了Seagen公司支付的2亿美元（约13.8亿元人民币）首付款并确认收入。 当年，公司营收14.26亿元，净利润2.76亿元，成功扭亏为盈。

6. Images

   • 
   • 

   View all